Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Bariatric surgery registry for quality control and investigational purposes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bariatric surgery | Procedure | All bariatric procedures |
| Measure | Description | Time Frame |
|---|---|---|
| Surgery type | Sleeve gastrectomy or Roux-Y gastric bypass (RYGBP) or Single anastomosis gastric bypass (SAGB) or biliopancreatic diversion (BPD/DS) or single anastomosis duodeno-ilial bypass (SADI) | 10 years |
| Percent total weight loss (%TWL) | [(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100 | 1 year from surgery |
| Percent total weight loss (%TWL) | [(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100 | 5 years from surgery |
| Percent total weight loss (%TWL) | [(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100 | 10 years from surgery |
| Percent BMI loss (%BMIL) | [BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100 | 1 year from surgery |
| Percent BMI loss (%BMIL) | [BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100 | 5 years from surgery |
| Percent BMI loss (%BMIL) | [BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100 | 10 years from surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Co-morbidity resolution | Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.) | 1 year from surgery |
| Co-morbidity resolution |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All morbidly obese individuals seeking bariatric surgery and approved by multidisciplinary bariatric committee.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sheba Medical Center | Recruiting | Ramat Gan | 65261 | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009767 | Obesity, Morbid |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D050110 | Bariatric Surgery |
| ID | Term |
|---|---|
| D049088 | Bariatrics |
| D000073319 | Obesity Management |
| D013812 | Therapeutics |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.)
| 5 years from surgery |
| Co-morbidity resolution | Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.) | 10 years from surgery |
| 30 day morbidity/mortality | 30 day morbidity/mortality according to Clavien Dindo criteria | up to 30 days from intervention |
| long-term morbidity/mortality | morbidity/mortality according to Clavien Dindo criteria after 30 days | 31 days to 10 years from surgery |
| D009750 |
| Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |